ALBT - Avalon GloboCare Corp.

3.63
-0.040   -1.102%

Share volume: 12,562
Last Updated: 05-06-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.08%

PREVIOUS CLOSE
CHG
CHG%
$3.67
-0.04
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024
Report Date 05-30-2024 08-14-2023 11-14-2023 11-12-2024 05-30-2024 08-19-2024 11-12-2024
Total revenue 296.165 K 306.905 K 331.290 K 321.321 K 314.588 K 327.887 K 345.159 K
Cost of revenue 451.555 K 0.000 0.000 1.066 M 0.000 0.000 343.360 K
Gross profit -155.390 K 306.905 K 331.290 K -744.560 K 314.588 K 327.887 K 1.799 K
    297.51% 7.95% -324.75% 142.25% 4.23% -99.45%  
Operating expenses 1.569 M 1.729 M 1.101 M -411.423 K 956.993 K 1.155 M 433.589 K
Selling general and admin 1.569 M 1.729 M 1.101 M -410.881 K 956.993 K 1.155 M 433.589 K
Research and development 0.000 0.000 0.000 -542.000 0.000 0.000 0.000
Total expenses 2.213 M 245.403 K 288.083 K 684.925 K 263.126 K 285.488 K 724.220 K
    -88.91% 17.39% 137.75% -61.58% 8.50% 153.68%  
Operating income -2.753 M -2.068 M -1.141 M -10.084 M -843.062 K -1.504 M -1.270 M
Ebit -2.764 M -2.654 M -1.390 M -10.092 M -843.062 K -1.505 M -1.132 M
Pretax income -2.920 M -2.747 M -1.485 M -9.895 M -1.368 M -2.132 M -1.679 M
    -5.91% -45.94% 566.28% -86.18% 55.91% -21.24%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -2.920 M -5.494 M -1.485 M -9.895 M -959.601 K -2.132 M -1.679 M
    -88.17% 72.97% -566.28% 90.30% -122.18% 21.24%